- **Q4 and full-year 2025 results**: Recursion Pharmaceuticals Inc. will provide business updates and report its fourth quarter and full year 2025 financial results on **February 25, 2026**, **before the open of the financial markets**. - **$(L)$earnings Call**: Recursion will host a public (L)earnings call on **February 25, 2026 at 8:00 am ET / 6:00 am MT / 1:00 pm GMT**, with a live stream broadcast from the company’s X, LinkedIn, and YouTube accounts; **investors, analysts, and the public** will be able to ask questions by submitting them via https://forms.gle/TQ4vgUTLKsFmikcu6.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9656441-en) on February 18, 2026, and is solely responsible for the information contained therein.